Pure Global

Unannounced Meal Handling of Advanced Closed Loop Insulin Delivery in Monitored Condition - Trial NCT04479826

Access comprehensive clinical trial information for NCT04479826 through Pure Global AI's free database. This phase not specified trial is sponsored by Sheba Medical Center and is currently Recruiting. The study focuses on type1diabetes. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT04479826
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT04479826
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Unannounced Meal Handling of Advanced Closed Loop Insulin Delivery in Monitored Condition

Study Focus

type1diabetes

Advanced hybrid closed loop system

Interventional

device

Sponsor & Location

Sheba Medical Center

Tel-Hashomer, Israel

Timeline & Enrollment

N/A

Jul 16, 2020

Jul 01, 2021

16 participants

Primary Outcome

Time in ranges

Summary

The study will follow participants for the periods of 3 months while using an advanced hybrid
 closed loop algorithm in free living conditions . Each period will have a different meal
 handling protocols. The objective is to identify the mitigation of the algorithm with
 different meal handling approaches.

ICD-10 Classifications

Type 1 diabetes mellitus
Type 1 diabetes mellitus with unspecified complications
Type 1 diabetes mellitus with other specified complications
Type 1 diabetes mellitus without complications
Type 1 diabetes mellitus with multiple complications

Data Source

ClinicalTrials.gov

NCT04479826

Device Trial